VERFORA has achieved significant growth in the last years via consequent organic growth and M&A: Hedoga Group with Iromedica and Dr. A&L Schmidgall Jul-20, Pharma Portfolio Dr. Wild May-21, Spagyros Jul-21, Cannaplant Nov-22, Padma Jan-23.The more VERFORA had been able to take over the distribution of strong brands in Switzerland in the last years: Omni-Biotic, ThermaCare, Boiron, Mustela and Uriage

- Member of Executive Board VERFORA (part of Galenica Group; VERFORA named Vifor Consumer Health until Jun-18), Deputy to the Division Manager Products & Brands- Marketing (3 Teams, 12 People) : Brand Plans, Marketing Plans, Marketing Execution- Marketing Services (1 Team, 8 People): Trade Marketing, Promotional Planning, Digital Transformation Marketing- Business Development (1 Team, 5 People): Strategic Planning, M&A, In-Licensing, Market Analysis, Product Innovation Process, Project Mgmt new Products, Concept Development

- Member of Executive Board VERFORA (former Vifor Consumer Health)- Strategic Planning: Strategic Priorities, Category Strategy, Core Processes- Business Services: Market Analysis, Product Innovation Process, Project Mgmt new Products, Marketing Services incl. Trade Marketing, Promotional Planning Process- 2 Teams, 10 People

- Main activities: company strategy, portfolio strategy and portfolio implementation in Galenicare- Juli-Oct 2018 non-formal member ; since Nov 2018 formal member- Galenica holds a minority share in Spagyros

- Member of Executive Board Vifor Consumer Health- Lead Marketing Consumer Health (4 Teams, 17 heads)- Lead Business Development & Licensing (1 Team, 2 heads) from Mrz-11 to Dec-12Vifor Consumer Health is one of the 3 leading Consumer Health companies in Switzerland.The major brands are Perskindol, Algifor, Triofan, Anti-Brumm & Magnesium Vital.The more there exist several international export markets, especially for Perskindol and Anti-Brumm.

Consumer Health Care SwitzerlandTherapeutic Area Management- Mgmt of Therapeutic Areas Pain & Inflammation and Cough, Cold & Respiratory with two Brand Managers: Strategy, Marketing, Life Cycle Mgmt- Focus on OTC with some Rx as well.- Portfolio about 35 mio CHF ex-factory sales.- Key brands: Algifor, Triofan (both category leaders and among biggest Swiss OTC brands), Itinerol, Pectocalmine, TriomerBusiness Development & Licensing- Consumer Healthcare Switzerland with one BD&L Officer- Portfolio Strategy- In-Licensing- Development projects- Out-Licensing support

Consmer Health Care International- Part of the Market Entry Team for Equazen eye q.- International Expansion of Equazen eye q by acquiring new distributors.- Market Entry Strategies & Launch Plans for Equazen eye q (Germany, France, Italy, Mexico, Canada).Consumer Health Care Switzerland & Contract Manufacturing- In-Licensing for Consumer Health Care Switzerland.- Out-Licensing of OTC products.

Consumer Health Care Switzerland- Product Mgmt for the Therapeutic Area Pain & Inflammation: Strategy, Marketing, Life Cycle Mgmt.- Focus on OTC with some Rx as well.- Portfolio about 13 mio CHF ex-factory sales.- Key brands: Algifor (leading Swiss OTC pain brand, among top OTC brands) & Itinerol B6.

Innovation services for kkiosk business

Diploma thesis MAS MTEC ETHZ